PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate. - Lin, D.; Morrison, L.; Pilon, D.; Benson, C.; Ghelerter, I.; Vermette-Laforme, M.; Lefebvre, P. (Value in Health, 2021)